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Abstract
An 18 month old 14 kg male with symptomatic Brugada syndrome underwent placement of an 
epicardial automatic implantable cardiac defibrillator using a single coil transvenous lead 
sutured to the anterolateral aspect of the left ventricle.                                                                 
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Introduction
Brugada Syndrome is a known cause of sudden cardiac death in young individuals without 
structural heart disease. The most valid therapy for symptomatic individuals is the use of an 
automatic implantable cardiac desfibrillator (AICD). Despite technological advances which 
have allowed the use of AICDs in children, there are still technical limitations in smaller 
individuals. Innovative implant approaches have been described in the literature [1,2]. However, 
there is paucity of data regarding AICDs implants in small pediatric patients with Brugada 
syndrome [3]. This case constitutes another example of the feasibility of using a transvenous 
catheters sutured to the epicardium in small pediatric patients.                                             
Case   Report                                                                                        
An 18 month-old previously healthy male presented to the emergency department with 
hemodynamically unstable ventricular tachycardia. His father had a diagnosis of asymptomatic 
Brugada syndrome. Tachycardia terminated spontaneously before external defibrillation was 
attempted. His baseline ECG showed a coved type Brugada syndrome pattern (Figure 1) and 
the implantation of an AICD was decided.
Due to his weight (14 kg), an epicardial approach was elected over a transvenous one. A 
standard transvenous single coil lead (GUIDANT Endotak Reliance SG SN 0180-102758) was 
sutured to the posterolateral epicardial aspect of the left ventricle, avoiding the left anterior 
descending coronary artery. An epicardial bipolar steroid eluting passive fixation catheter 
(Medtronic Capsure Epi Model 4968) was sutured to the right ventricular epicardium for 
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sensing and pacing. Leads were tunneled to the abdomen and the AICD device (GUIDANT 
VITALITYTM REF 0180 VR) was placed in a sub rectus pocket in the right hypochondrium 
(Figure 2). Ventricular fibrillation was induced with a T wave shock and it was successfully 
recognized by the device and terminated with 20 Joules.  The patient was admitted to the 
pediatric cardiovascular recovery unit and had an uneventful postoperative course until he was 
discharged, 2 days following the implant. 
Figure 1: Precordial leads showing sinus rhythm and a type I Brugada pattern.
Figure 2: AP chest and abdominal X ray showing the leads and the generator position. The single coil transvenous 
defibrillator lead is sutured to the postero-lateral aspect of the left ventricle.                                           
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Discussion
AICDs   remain   the   only   recognized   effective   therapy   for   sudden   death   prevention   in 
symptomatic Brugada syndrome patients. Difficulties arise with smaller pediatric patients due to 
the leads and defibrillators sizes. Concerns are related to the development of venous occlusions 
and to local complications like wound dehiscence or skin erosion.                           
The alternatives for small patients are not optimal. Pericardial patches can be used, but there are 
limitations related to the potential development of severe complications, including constrictive 
pericarditis or postpericardiotomy syndrome. There are previous reports of different innovative 
alternatives for pediatric patients requiring AICDs using transvenous or subcutaneous coils in 
non-traditional positions, hence avoiding the occurrence of long term vascular complications 
[1,2,4]. However, with subcutaneous coils the potential for coil damage or migration exists and 
has been described as a complication to this approach [2].                                  
In our patient a single coil transvenous catheter sutured to the epicardium was used. This 
technique has been previously described in a study by Cannon et al [1]. Due to the potential for 
cardiac strangulation with the lead secondary to cardiac somatic growth, the great vessels and 
the coronary arteries were carefully avoided. The lead was placed in the posterolateral aspect of 
the left ventricle, laterally to the left anterior descending coronary artery. In addition, with this 
lead position, an adequate defibrillation vector was obtained by placing the generator in a pocket 
created in the left hypochondrium (Figure 2). Defibrillation thresholds at implant have been 
described to be adequate with these novel techniques for AICD placements.  Cannon and co-
workers [1] postulated that AICDs should be tested after chest closure with sternal wires, due to 
the fact that air is a poor conductor potentially affecting defibrillation thresholds. In our case it 
was tested before closure not affecting the results. Testing before closing the chest allows for 
the possibility of changing the position of the coil in case the threshold was high.           
Conclusion
The placement of a transvenous defibrillator lead in the pericardial aspect of the heart appears to 
be a good alternative for smaller patients with the need for an AICD. Its location in the lateral 
aspect of the left ventricle to the left of the left anterior descending coronary artery may be a 
good position to avoid cardiac strangulation and compromise of the coronary vasculature, and 
additionally providing a good defibrillation vector.                                                             
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